73042-0201 DANYELZA - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

73042-0201

Brand Name:

DANYELZA

Generic Name:

Naxitamab

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: NAXITAMAB

Strength: 40.0

Unit: mg/10mL

Packages:

Code: 73042-0201-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (73042-201-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Nov. 25, 2020

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

GD2

Orphan Drug Designation:

Status:

In Use